Vyriad Begins First-in-Human Trial of In Vivo CAR T Therapy VV169 - Summary - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Vyriad Begins First-in-Human Trial of In Vivo CAR T Therapy VV169

Phase I study will test whether a targeted lentiviral vector can generate BCMA-directed CAR T cells inside patients with multiple myeloma

  • September 28, 2026

  • 3 min

Share

Original Source(s)

Vyriad Begins First-in-Human Trial of In Vivo CAR T Therapy VV169

  • September 28, 2026

Related Content

Bridging the PSMA PET/CT access gap in prostate cancer: evidence, barriers, and priorities for implementation

Deep learning-based segmentation of peritoneal cancer index regions from CT imaging

Multicentre evaluation of artificial intelligence risk classification for detection of clinically significant prostate cancer on biparametric MRI